Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.

[1]  Andrew B West,et al.  Molecular pathophysiology of Parkinson's disease. , 2005, Annual review of neuroscience.

[2]  Gonçalo R. Abecasis,et al.  GOLD-Graphical Overview of Linkage Disequilibrium , 2000, Bioinform..

[3]  Eden R Martin,et al.  Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. , 2004, American journal of human genetics.

[4]  Murat Gunel,et al.  Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome , 2005, Science.

[5]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[6]  E R Martin,et al.  Letter to the Editor Correcting for a Potential Bias in the Pedigree Disequilibrium Test , 2022 .

[7]  Philippe Amouyel,et al.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. , 2004, Lancet.

[8]  S. Omachi.  FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain , 2000 .

[9]  L. Stefanis,et al.  Regulation of α‐synuclein by bFGF in cultured ventral midbrain dopaminergic neurons , 2003 .

[10]  Gene W. Yeo,et al.  Noncoding RNAs in the mammalian central nervous system. , 2006, Annual review of neuroscience.

[11]  A. Björklund,et al.  Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System , 2002, The Journal of Neuroscience.

[12]  R. McKay,et al.  A Specific Survival Response in Dopamine Neurons at Most Risk in Parkinson's Disease , 2006, The Journal of Neuroscience.

[13]  A Dürr,et al.  Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. , 2004, Lancet.

[14]  Mariza de Andrade,et al.  High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.

[15]  C. Svendsen,et al.  Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. , 2007, Human molecular genetics.

[16]  C. V. van Duijn,et al.  Parkinson's disease: piecing together a genetic jigsaw. , 2003, Brain : a journal of neurology.

[17]  L. Stefanis,et al.  Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons. , 2003, Journal of neurochemistry.

[18]  T. Chase,et al.  Muscarinic Receptor Stimulation Induces Translocation of an α-Synuclein Oligomer from Plasma Membrane to a Light Vesicle Fraction in Cytoplasm* , 2001, The Journal of Biological Chemistry.

[19]  M. Farrer.  Genetics of Parkinson disease: paradigm shifts and future prospects , 2006, Nature Reviews Genetics.

[20]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[21]  Philippe Amouyel,et al.  α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[22]  A. Singleton,et al.  Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients , 2005, BMC neurology.

[23]  E. Martin,et al.  A test for linkage and association in general pedigrees: the pedigree disequilibrium test. , 2000, American journal of human genetics.

[24]  A. Akaike,et al.  FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain. , 2000, Biochemical and biophysical research communications.

[25]  K. Kosik.  The neuronal microRNA system , 2006, Nature Reviews Neuroscience.

[26]  Eden R Martin,et al.  Accounting for linkage in family-based tests of association with missing parental genotypes. , 2003, American journal of human genetics.

[27]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.

[28]  Nobuyuki Itoh,et al.  Preferential neurotrophic activity of fibroblast growth factor‐20 for dopaminergic neurons through fibroblast growth factor receptor‐1c , 2003, Journal of neuroscience research.

[29]  John G Doench,et al.  Specificity of microRNA target selection in translational repression. , 2004, Genes & development.

[30]  N. Itoh,et al.  Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.

[31]  Florian Caiment,et al.  A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep , 2006, Nature Genetics.

[32]  J. Schaack,et al.  Overexpression of human α-synuclein causes dopamine neuron death in primary human mesencephalic culture , 2002, Brain Research.

[33]  A Dürr,et al.  Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease , 2004, The Lancet.

[34]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[35]  J. Haines,et al.  Complete genomic screen in Parkinson disease: evidence for multiple genes. , 2001, JAMA.

[36]  Florian Caiment,et al.  RNAi-Mediated Allelic trans-Interaction at the Imprinted Rtl1/Peg11 Locus , 2005, Current Biology.